QNTM
Quantum BioPharma Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$2.38
−2.46%Institutional positioning
13F filings over the trailing two quarters
New 10Increased 13Reduced 6Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| AdvisorShares Investments LLC | Increased | 203,564 | Aug 11, 2026 |
| JANE STREET GROUP, LLC | Increased | 48,355 | Aug 14, 2026 |
| Platform Technology Partners | Unchanged | 41,116 | Jul 24, 2026 |
| UBS Group AG | Increased | 33,405 | Aug 13, 2026 |
| JANE STREET GROUP, LLC | Increased | 31,501 | May 12, 2026 |
| Steward Partners Investment Advisory, LLC | Increased | 27,881 | Aug 13, 2026 |
| CITADEL ADVISORS LLC | Unchanged | 15,863 | Sep 2, 2026 |
| CITADEL ADVISORS LLC | Unchanged | 15,863 | May 15, 2026 |
| MAREX GROUP PLC | Increased | 13,468 | May 13, 2026 |
| Marex Group plc | Reduced | 13,436 | Aug 14, 2026 |
| VIRTU FINANCIAL LLC | Increased | 12,282 | May 14, 2026 |
| MARINER, LLC | New Position | 10,059 | May 13, 2026 |
| Mariner, LLC | Reduced | 10,000 | Aug 13, 2026 |
| UBS GROUP AG | Increased | 7,237 | May 5, 2026 |
| NBC SECURITIES, INC. | New Position | 7,000 | Jul 21, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings